News
ACR Position Paper: Cost Impact of Rheumatologic Care
The American College of Rheumatology (ACR) has published evidence that rheumatologic care can save more than $2700 per patient per year.
FDA Approves Canakinumab for Gout Flares
Medscape
SGLT2 Inhibitors as Gout Treatment
MedPage Today
Patients with gout and type 2 diabetes treated with SGLT2 inhibitors not only had reduced numbers of gout flares, but also lived longer compared with other such patients receiving other medications, researchers said.
2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria
The American College of Rheumatology (ACR) and EULAR have combined efforts to establish an international multidisciplinary Steering Committee to develop classification criteria for the new antiphospholipid syndrome (APS) to be applied in observational studies and clinical trials.
Dr. Naomi Rothfield (1929 – 2023)
Medical schools are rife with mentors. In my rheumatology fellowship I had tow great mentors, Peter Lipsky and Morris Ziff. They introduced me, and other young rheumatologists, to other rheumatology giants and mentors, including Dr. Naomi Rothfield - who they often spoke of as a leader worth following. She was engaging and inclusive. And she stood out as one of the few strong rheumatology department chairs in the 1980s. Naomi F. Rothfield, MD, famed leader from the University of Connecticut, passed away on Sunday, July 2, 2023, at the age of 94.
Gut Microbiome Differences Antedate JIA Development
Researchers have shown that gut microbiome differences may be associated with later development of juvenile idiopathic arthritis (JIA), and that such differences are present years before the disease is diagnosed.
Hip Replacement Surgery After Age 90
EurekAlert!
Before You Know It (8.25.2023)
Dr. Jack Cush comments on the news and journal articles from the past week on RheumNow.com: VEXAS scoring, scleroderma sine scleroderma and head scratchers from southeast Asia.
Biologic Adherence and Drug Survival in RA Patients
A real-world rheumatoid arthritis (RA) cohort study from Israel shows significant variability of drug survival using biologic disease-modifying anti-rheumatics drugs (bDMARDs) and targeted synthetic DMARDs (tsDMARDs).
ACR Guidelines for Interstitial Lung Disease in Patients with Rheumatic Conditions
ACR
WSJ: Do Younger or Older Doctors Get Better Results?
A recent Wall St. Journal essay (by AB Jena and C Worsham) suggests that a physician’s effectiveness has less to do with age than with how many patients they see and how well they stay up to date on research.
